Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Celera Diagnostics To Open Genotyping Facility
Celera Diagnostics, a $300 million joint venture of Celera Genomics and Applied Biosystems, will open an industrial-scale facility to perform high-volume genotyping and gene expression research. Applied Biosystems, a manufacturer of gene sequencing hardware, is currently expanding at a building in the Hacienda Business Park in Pleasanton, Calif., where renovations will be completed around the end of fiscal 2002. Celera Genomics and Applied Biosystems are both owned by Applera.
Bio-Tech Imaging Opens Shreveport Plant
Bio-Tech Imaging (BTI), based in Frederick, Md., has opened a 33,000-sf production plant in Shreveport. The $15 million facility will produce the company’s “Tagger”AIDS-detection kits. Currently the kits are used for private scientific research. BTI is awaiting FDA approval to extend marketing of the kits to hospitals, doctors, and blood banks. BTI hopes to occupy the plant by early 2002.
Maricopa County Medical Examiner Builds New Office
Maricopa County Medical Examiner office and parking structure recently broke ground. The St. Louis firm HERA Inc. provided lab planning for the 62,000-sf facility as part of the team led by The Stichler Group in Phoenix. The facility, programmed for a staff of 114, features autopsy suites, DNA and trace evidence labs, and pathology, toxicology, histology and forensic science labs.
SEC To Build HQ at Station Place
The U.S. Securities and Exchange Commission has decided that its new 650,000-sf headquarters—called Station Place—will be built adjacent to Union Station and the Thurgood Marshall Building. The architect for the project is New York-based Kevin Roche John Dinkeloo and Associates; it will be developed by Louis Dreyfus Properties, also of New York. December 2003 is the scheduled occupancy date.
CDC To Build Infectious Diseases Lab
The Centers for Disease Control and Prevention is preparing to begin construction of the $132 million Emerging Infectious Diseases Laboratory. The lab will house multiple research activities, providing approximately 370,000 gsf of research space for 459 personnel. The project scope includes a ten-story tower containing a combination of labs, lab support, and scientific personnel workstations. An attached five-story structure will house specialized lab spaces. Together, the labs will accommodate Biosafety Level 2, 3, and 4 work.